Clorox (CLX)
(Delayed Data from NYSE)
$162.77 USD
+0.07 (0.04%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $162.84 +0.07 (0.04%) 5:46 PM ET
2-Buy of 5 2
D Value A Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$162.77 USD
+0.07 (0.04%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $162.84 +0.07 (0.04%) 5:46 PM ET
2-Buy of 5 2
D Value A Growth D Momentum B VGM
Zacks News
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Will General Mills (GIS) Top Estimates in Q4 Earnings Release?
by Zacks Equity Research
General Mills' (GIS) Q4 results are likely to reflect gains from the Accelerate strategy amid soft Pet unit sales and cost inflation.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Clorox's (CLX) Strategic Efforts Appear Good
by Zacks Equity Research
Clorox (CLX) benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
Why Is Clorox (CLX) Down 8.2% Since Last Earnings Report?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Clorox (CLX) Benefits From Strategic Actions Amid High Costs
by Zacks Equity Research
Clorox (CLX) is poised for significant expansion by focusing on the implementation of its pricing strategy and cost saving initiatives amid cost-related hurdles.
Here's Why Clorox (CLX) is a Strong Growth Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Clorox (CLX) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Clorox (CLX) Q3 Earnings Beat Estimates, Revenues Down Y/Y
by Zacks Equity Research
Clorox's (CLX) third-quarter fiscal 2024 bottom line benefits from pricing actions and cost-saving initiatives. The company also boasts a solid innovation pipeline.
Clorox (CLX) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Clorox (CLX) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Here's How Clorox (CLX) is Placed Ahead of Q3 Earnings Release
by Zacks Equity Research
Clorox (CLX) third-quarter results are likely to reflect challenges related to continued impacts of the recent cyberattack incident, inflationary costs and elevated SG&A expense.
Why Clorox (CLX) Might Surprise This Earnings Season
by Zacks Equity Research
Clorox (CLX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What Analyst Projections for Key Metrics Reveal About Clorox (CLX) Q3 Earnings
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Clorox (CLX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Church & Dwight (CHD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Church & Dwight (CHD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Clorox (CLX) Q3 Earnings Expected to Decline
by Zacks Equity Research
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble (PG) Q3 Earnings Beat Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 7.04% and 1.41%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights Colgate-Palmolive, Henkel, Church & Dwight and The Clorox
by Zacks Equity Research
Colgate-Palmolive, Henkel, Church & Dwight and The Clorox have been highlighted in this Industry Outlook article.
4 Soap & Cleaning Materials Stocks to Watch Amid Favorable Industry Trends
by Rajani Lohia
The soap and cleaning materials industry stays composed, backed by efforts to improve sales, including pricing actions, innovation, digital transformation and brand building, amid elevated costs. Players like CL, HENKY, CHD and CLX look well-poised.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Clorox's (CLX) Strategic Efforts Appear Good
by Zacks Equity Research
Clorox (CLX) benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.
Clorox (CLX) Falls More Steeply Than Broader Market: What Investors Need to Know
by Zacks Equity Research
Clorox (CLX) closed at $148.71 in the latest trading session, marking a -1.94% move from the prior day.
Colgate (CL) Benefits From Strong Pricing & Other Efforts
by Zacks Equity Research
Colgate (CL) has been on the growth track, driven by robust pricing actions, solid business momentum and accelerated revenue growth management plans.
Is Clorox (CLX) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Clorox (CLX) and General Mills (GIS) have performed compared to their sector so far this year.
Here's Why RH's Earnings Are Likely to Decline Y/Y in Q4
by Zacks Equity Research
RH's fiscal Q4 results are likely to reflect high mortgage rates, a soft luxury housing market and clearance pressure.
Clorox (CLX) Benefits From Strategic and Pricing Efforts
by Zacks Equity Research
Clorox (CLX) benefits from pricing actions and cost-saving initiatives. The company also boasts a solid innovation pipeline.